Mar 15, 2021 07:11AM

Nov 16, 2020 06:55AM

Sep 16, 2020 09:00AM

Sep 16, 2020 07:00AM

Jul 9, 2020 07:00AM

Jul 7, 2020 06:41AM

Jun 29, 2020 07:00AM MATEON ANNOUNCES $2 MILLION FINANCING WITH GOLDEN MOUNTAIN PARTNERS TO CONDUCT CLINICAL TRIAL OF OT-101 AGAINST COVID19

Jun 24, 2020 07:00AM

Jun 24, 2020 07:00AM

Jun 22, 2020 08:00AM

Jun 22, 2020 08:00AM

Jun 10, 2020 08:00AM

May 5, 2020 06:00AM

Apr 27, 2020 08:00AM Mateon Announces the Filing of an IND with US FDA to Evaluate its Antisense Drug Candidate OT-101 in COVID-19 patients

Apr 6, 2020 08:00AM

Apr 2, 2020 08:00AM

Mar 25, 2020 08:00AM

Mar 19, 2020 08:00AM

Mar 18, 2020 08:00AM

Mar 2, 2020 07:50AM

Dec 27, 2019 08:30AM Mateon Therapeutics Team Publishes a New Peer-Reviewed Oncology Article on the Positive Clinical Study Results for Its Lead Anti-Leukemia Drug Combretastatin A1 Plus Cytarabine in Adult Patients With

Dec 23, 2019 02:30PM

Dec 23, 2019 09:32AM

Dec 23, 2019 09:30AM

Dec 11, 2019 08:30AM

Dec 2, 2019 09:15AM

Nov 18, 2019 09:25AM

Nov 4, 2019 10:30AM Mateon completes its acquisition of PointR Data Inc.

Oct 23, 2019 01:00PM

Sep 23, 2019 09:00AM

Sep 9, 2019 08:30AM

Aug 19, 2019 09:15AM

Jul 30, 2019 08:55AM

Jul 16, 2019 10:31AM

Jun 10, 2019 08:30AM Mateon and Oncotelic Report on Continuing Integration of the two Businesses

Oct 25, 2018 04:30PM

Aug 17, 2018 11:31AM

Aug 17, 2018 08:52AM

Aug 17, 2018 08:50AM

Apr 16, 2018 04:35PM

Oct 30, 2017 08:45AM

Sep 6, 2017 09:00AM Mateon Therapeutics to Present at the 19th Annual Rodman and Renshaw Global Investment Conference on September 12, 2017

Aug 16, 2017 08:00AM

Aug 2, 2017 04:30PM

Aug 1, 2017 07:30AM

Jul 31, 2017 07:30AM

Jun 28, 2017 07:34AM

Jun 28, 2017 07:30AM

Jun 12, 2017 07:30AM Mateon Therapeutics Provides Update on its Clinical Trial Programs and Milestones

Jun 7, 2017 07:45AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All